Debora Macis

17PUBLICATIONS
69CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Models of care and place of birthPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 16, 2025
Impact of Epigenome-Wide Methylation and Breast Cancer Recurrence in Women Tested Negative for BRCA Genes: The Breast Methylation Risk (BREMERI) Study.

Silvia Polidoro, Harriet Johansson, Giovanni Cugliari

|Apr 28, 2025
Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial.

Harriet Johansson, Debora Macis, Martino Oliva

|Jul 13, 2024
A Mediation Analysis of Obesity and Adiponectin Association with Postmenopausal Breast Cancer Risk: A Nested Cohort Study in the International Breast Cancer Intervention Study II (IBIS-II) Prevention Trial.

Debora Macis, Federica Bellerba, Valentina Aristarco

|Apr 13, 2024
Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer-Evidence from a 17-Year Follow-Up Study.

Massimiliano Ruscica, Chiara Macchi, Sara Gandini

|Mar 26, 2024
Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker Trial.

Valentina Aristarco, Davide Serrano, Patrick Maisonneuve

|Jan 18, 2024
Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation.

Harriet Johansson, Aliana Guerrieri-Gonzaga, Sara Gandini

Pageof 3

Frequent Collaborators

12 joint publications

Bernardo Bonanni

11 joint publications

Sara Gandini

11 joint publications

Harriet Johansson

10 joint publications

Valentina Aristarco